178 related articles for article (PubMed ID: 9597247)
1. In vitro antibiotic synergy against Flavobacterium meningosepticum: implications for therapeutic options.
Di Pentima MC; Mason EO; Kaplan SL
Clin Infect Dis; 1998 May; 26(5):1169-76. PubMed ID: 9597247
[TBL] [Abstract][Full Text] [Related]
2. Successful combination vancomycin and rifampin therapy in a newborn with community-acquired Flavobacterium meningosepticum neonatal meningitis.
Tizer KB; Cervia JS; Dunn AM; Stavola JJ; Noel GJ
Pediatr Infect Dis J; 1995 Oct; 14(10):916-7. PubMed ID: 8584328
[No Abstract] [Full Text] [Related]
3. Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review.
Bloch KC; Nadarajah R; Jacobs R
Medicine (Baltimore); 1997 Jan; 76(1):30-41. PubMed ID: 9064486
[TBL] [Abstract][Full Text] [Related]
4. Role of vancomycin in the treatment of bacteraemia and meningitis caused by Elizabethkingia meningoseptica.
Jean SS; Hsieh TC; Ning YZ; Hsueh PR
Int J Antimicrob Agents; 2017 Oct; 50(4):507-511. PubMed ID: 28705672
[TBL] [Abstract][Full Text] [Related]
5. [Purulent meningitis due to flavobacterium meningosepticum in Cameroonian children].
Kokindombo PO; Nko'o Amvenne S; Ndjitoyap Ndam EC; Wouaffo Ndayo M; Tangam Ouambo T; Tietche F; Foumbi J; Borderon JC; Laugier J; Mbede J
Ann Pediatr (Paris); 1991 Sep; 38(7):491-5. PubMed ID: 1952709
[TBL] [Abstract][Full Text] [Related]
6. Flavobacterium meningosepticum bacteremia: an analysis of 16 cases.
Liu CE; Wong WW; Yang SP; Wang FD; Fung CP; You KW; Liu CY
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Mar; 62(3):125-32. PubMed ID: 10222599
[TBL] [Abstract][Full Text] [Related]
7. Flavobacterium meningosepticum bacteremia in an adult with acute leukemia. Use of rifampin to clear persistent infection.
Hirsh BE; Wong B; Kiehn TE; Gee T; Armstrong D
Diagn Microbiol Infect Dis; 1986 Jan; 4(1):65-9. PubMed ID: 3455909
[TBL] [Abstract][Full Text] [Related]
8. Chryseobacterium (Flavobacterium) meningosepticum outbreak associated with colonization of water taps in a neonatal intensive care unit.
Hoque SN; Graham J; Kaufmann ME; Tabaqchali S
J Hosp Infect; 2001 Mar; 47(3):188-92. PubMed ID: 11247678
[TBL] [Abstract][Full Text] [Related]
9. Atypical Chryseobacterium meningosepticum and meningitis and sepsis in newborns and the immunocompromised, Taiwan.
Chiu CH; Waddingdon M; Greenberg D; Schreckenberger PC; Carnahan AM
Emerg Infect Dis; 2000; 6(5):481-6. PubMed ID: 10998378
[TBL] [Abstract][Full Text] [Related]
10. Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing.
Fraser SL; Jorgensen JH
Antimicrob Agents Chemother; 1997 Dec; 41(12):2738-41. PubMed ID: 9420049
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic resistance pattern of Flavobacterium meningosepticum.
Raimondi A; Moosdeen F; Williams JD
Eur J Clin Microbiol; 1986 Aug; 5(4):461-3. PubMed ID: 3489618
[No Abstract] [Full Text] [Related]
12. [Clinical observation of neonatal meningitis caused by flavobacterium meningosepticum].
Lin CH; Huang FY
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1991; 32(3):171-6. PubMed ID: 1776441
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment with linezolid and rifampicin of meningitis due to methicillin-resistant Staphylococcus epidermidis refractory to vancomycin treatment.
Kruse AJ; Peerdeman SM; Bet PM; Debets-Ossenkopp YJ
Eur J Clin Microbiol Infect Dis; 2006 Feb; 25(2):135-7. PubMed ID: 16474940
[No Abstract] [Full Text] [Related]
14. Flavobacterium meningosepticum.
Ratner H
Infect Control; 1984 May; 5(5):237-9. PubMed ID: 6563023
[TBL] [Abstract][Full Text] [Related]
15. Flavobacterium breve meningitis in a dog.
Haburjak JJ; Schubert TA
J Am Anim Hosp Assoc; 1997; 33(6):509-12. PubMed ID: 9358418
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility of flavobacteria as determined by agar dilution and disk diffusion methods.
Chang JC; Hsueh PR; Wu JJ; Ho SW; Hsieh WC; Luh KT
Antimicrob Agents Chemother; 1997 Jun; 41(6):1301-6. PubMed ID: 9174188
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.
Bae S; Kim MC; Park SJ; Kim HS; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP
Antimicrob Agents Chemother; 2016 Nov; 60(11):6774-6779. PubMed ID: 27600048
[TBL] [Abstract][Full Text] [Related]
18. Identification and distribution of Flavobacterium meningosepticum in clinical material.
Holmes B
J Appl Bacteriol; 1987 Jan; 62(1):29-41. PubMed ID: 3571032
[TBL] [Abstract][Full Text] [Related]
19. Analysis of an outbreak due to Chryseobacterium meningosepticum in a neonatal intensive care unit.
Tekerekoglu MS; Durmaz R; Ayan M; Cizmeci Z; Akinci A
New Microbiol; 2003 Jan; 26(1):57-63. PubMed ID: 12578312
[TBL] [Abstract][Full Text] [Related]
20. Experimental study of the efficacy of linezolid alone and in combinations against experimental meningitis due to Staphylococcus aureus strains with decreased susceptibility to beta-lactams and glycopeptides.
Cabellos C; Garrigós C; Taberner F; Force E; Pachón-Ibañez ME
J Infect Chemother; 2014 Sep; 20(9):563-8. PubMed ID: 24973908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
